• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DSM BIOMEDICAL MESO BIOMATRIX ACELLULAR PERITONEUM MATRIX; MESH, SURGICAL, COLLAGEN, PLASTIC AND RECONSTRUCTIVE SURGERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DSM BIOMEDICAL MESO BIOMATRIX ACELLULAR PERITONEUM MATRIX; MESH, SURGICAL, COLLAGEN, PLASTIC AND RECONSTRUCTIVE SURGERY Back to Search Results
Model Number 30055-06
Device Problem Insufficient Information (3190)
Patient Problems Edema (1820); Erythema (1840); Unspecified Infection (1930); Pain (1994); Swelling (2091); Organ Dehiscence (2502)
Event Date 01/18/2016
Event Type  Injury  
Manufacturer Narrative
Review of the device history records does not have deviations that would contribute to the reported complications.The product met all pre-determined acceptance criteria.Review of sterilization records indicate the product was processed in accordance with product requirements and met all pre-determined acceptance criteria for sterility.The cause of the complication can not be determined from the provided information or the manufacturing records.
 
Event Description
The patient presented with capsular contracture of the left breast following a prior breast reconstruction.On (b)(6) 2015, the left breast was revised with capsulectomy, meso biomatrix implantation and implantation of a new breast implant (size and manufacturer not reported).Approximately 6 months later, she presented with a clinically infected left breast.It was described as diffuse redness and pain over the entire breast with some fluid surrounding the implant and a little edema.She had no fever.She was admitted to the hospital and started on intravenous antibiotics.After 2 days of iv antibiotics the infection worsened with dehiscence of the surgical scar.Therefore, the breast implant and meso biomatrix were surgically removed.Prior to removal, meso biomatrix was observed to be integrated at the periphery of the device but not in the center.The infection and dehiscence were reported to have resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MESO BIOMATRIX ACELLULAR PERITONEUM MATRIX
Type of Device
MESH, SURGICAL, COLLAGEN, PLASTIC AND RECONSTRUCTIVE SURGERY
Manufacturer (Section D)
DSM BIOMEDICAL
735 pennsylvania drive
exton PA 19341
Manufacturer Contact
forde hansell
735 pennsylvania drive
exton, PA 19341
4847132152
MDR Report Key5471832
MDR Text Key39424978
Report Number2530154-2016-00005
Device Sequence Number1
Product Code OXH
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K094061
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date10/31/2015
Device Model Number30055-06
Device Lot NumberC0767
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/12/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/28/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-